knowledge -WSS

knowledge

author：knowledge 2025-09-28 23:49:43 - browse：7871

TALLINN, Estonia -- A Belarusian journalist was sentenced Friday to four years in prison after being convicted of aiding extremist activities as the authoritarian country continues a severe crackdown on the opposition and independent reporting.

The trial of video journalist Pavel Padabed was held behind closed doors. His conviction and sentencing were reported by the Belarusian Association of Journalists.

Padabed worked with Belsat, a Polish-funded satellite channel that broadcasts into Belarus and is considered by the Belarusian government to be “extremist media.”

The journalists' association said material presented at his trial included investigative programs about the disappearance of a videographer and the 2016 car bombing in Ukraine of TV journalist Pavel Sharemet.

Belarus President Alexander Lukashenko, in power since 1994, has taken an increasingly repressive line toward the opposition and independent journalists since mass protests engulfed the country in 2020 following a presidential election that gave him a sixth term in office but was widely regarded as fraudulent.

The journalists' association says 34 journalists are currently behind bars.

More than 35,000 people were arrested during the 2020 protests, and many were severely beaten by police. The Belarusian human rights group Viasna says there are nearly 1,500 political prisoners in the country.

Exiled opposition leader Sviatlana Tsikhanouskaya, who ran against Lukashenko in 2020, met Friday with European Council President Charles Michel and EU foreign policy chief Josep Borrell.

Afterward, the European Council issued a statement calling on Belarus to stop allowing Russia to base troops there for use in the war in Ukraine and end the deployment there of Russian tactical nuclear weapons.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

leisure time

WSS

Former Pear Therapeutics executives start new VC firm

Is there really a nursing shortage in the U.S.?

Health tech investors get more selective as pandemic boom fades

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Meadows told special counsel he could not recall Trump ever declassifying Mar

The problems with dementia villages

leisure time

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

FDA clears Verve to begin U.S. study of gene

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Abortion policy in the spotlight at Republican debate

Malaria cases in Florida and Texas: Here’s what you need to know

Former Pear Therapeutics executives start new VC firm

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Roche's accidental data boosts hopes for anti

Medicare proposal to cover medical devices draws a mixed reaction

FDA advisory panel to debate high blood pressure devices

focus

National associations that represent hospice owe an apology

Former Pear Therapeutics executives start new VC firm

Merck, Daiichi strike cancer drug pact worth up to $22 billion

ADCs take center stage as promising cancer treatments

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Trans patients at the end of life deserve respect and dignity

focus

knowledge

leisure time

knowledge